ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Mylan Recalls Three Lots of Nizatidine Capsules americanpharmaceuticalreview
January 14, 2020Mylan announced its U.S. based Mylan Pharmaceuticals business is conducting a voluntary nationwide recall, to the consumer level, of three lots of Nizatidine Capsules, USP (including the 150mg and 300mg strengths).
Pharma Sources Insight July 2025
